Neuropace, Inc. NPCE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$21.57M-0.5% | -$21.47M+10.5% | -$23.99M+7.5% | -$25.94M-4.6% | -$24.81M+8.6% | ||
| $340K+3.3% | $329K+10.8% | $297K0.0% | $297K0.0% | $297K+1.4% | ||
| $10.74M-3.1% | $11.09M0.0% | $11.09M+0.3% | $11.05M+6.6% | $10.37M+0.8% | ||
| -$9.93M+13.7% | -$11.51M+29.4% | -$16.31M-1.4% | -$16.09M+10.1% | -$17.9M+0.3% | ||
| $412K+24.1% | $332K+21.2% | $274K-20.3% | $344K+43.9% | $239K-21.9% | ||
| -$412K-24.1% | -$332K-119% | $1.73M-45.3% | $3.16M-51.9% | $6.56M-27.1% | ||
| —— | —— | —— | —— | $49.55M— | ||
| —— | —— | —— | —— | $25.36M+486% | ||
| —— | —— | —— | —— | —— | ||
| -$10.25M+12.8% | -$11.75M+29.2% | -$16.58M-0.9% | -$16.43M+9.4% | -$18.14M+0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuropace, Inc. generate?
- Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
- What is Neuropace, Inc.'s free cash flow?
- After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
- Where does Neuropace, Inc.'s cash flow data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
